HOME >> BIOLOGY >> NEWS
Up to one-third of all cancer cases may be prevented by healthy diets and exercise, notes FANSA

CHICAGO -- Healthy diets and exercise may prevent as many cases of cancer in the United States as not smoking, according to a recent statement by the Food and Nutrition Science Alliance (FANSA). Cancer kills more than 500,000 Americans every year. In a review of cancer research, FANSA found overwhelmingly conclusive evidence that the risk of several types of cancer can be dramatically lowered through healthy dietary practices and exercise.

"In terms of cancer prevention, a healthy diet and exercise are as important as not smoking," says Dennis Savaiano, Ph.D., chair of FANSA and Professor of Foods and Nutrition at Purdue University. "Approximately one-third of cancer cases are attributed to smoking, one-third to poor diet and lack of exercise, and one-third to genetic or other factors. Most Americans are already aware of the detrimental effects of smoking, but poor diet is cause for alarm. We need to initiate changes in behavior now, in order to reduce the number of cancer-related deaths in the years to come."

The FANSA Statement, "Diet and Cancer Prevention in the United States," specifically urges Americans to take the following steps to reduce their cancer risk:

  • Eat plenty of fruits, vegetables, whole grains, and legumes in accordance with the USDA Food Guide Pyramid.
  • Avoid high calorie foods with little nutritional value.
  • Choose activities that involve moderate or vigorous exercise.
  • Limit or abstain from alcohol intake.

The FANSA statement, which can be viewed at www.faseb.org/ascn/fansa12-99.htm, is the first step in a nationwide call for action. In order to effect a change, all food, nutrition, fitness, health, and government organizations must strive to create consumer demand for a healthy lifestyle.


'"/>

Contact: Dennis Savaiano
savaiano@cfs.purdue.edu
765-494-8210
Institute of Food Technologists
23-Feb-2000


Page: 1

Related biology news :

1. Americans still consume one-third of calories from low-nutrient tip of the pyramid
2. Leader in cancer treatment and prevention research honored
3. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
4. Chemical derived from vitamin-E shows early promise as cancer drug
5. New molecular link key to cellular proteins involved in cancer progression, other diseases
6. Phase II trials of second-generation antisense cancer drug planned following successful early study
7. Trial shows which brain cancer patients benefit from temozolomide
8. Genetic differences might help distinguish thyroid cancers
9. Evidence builds for potential new cancer drug target
10. New sequence involved in DNA replication timing may aid in cancer detection
11. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/29/2016)... , November 29, 2016 Nearly one billion ... Continue Reading ... ... part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The ...
(Date:11/22/2016)... Nov. 22, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Healthcare and Life Sciences Awards as "Most Outstanding ... an unprecedented year of recognition and growth for MedNet, ... 15 years. iMedNet ™ , ...
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. ... billion KRW (US $18.9M) Series A financing. This financing ... G.N. Tech Venture and SNU Bio Angel. This new ... 30.5 billion KRW (US $27.7M) since its founding in ... to bolster the development and commercialization of its immuno-oncology ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... I/II dose escalation and expansion clinical trial for its lead drug candidate, AC0010, ... purpose of the trial was to determine the safety, antitumor activity, and recommended ...
(Date:12/7/2016)... , Dec. 7, 2016 Neogen Corporation (NASDAQ: ... Dr. Dan Kephart as its chief science ... will assume his responsibilities at Neogen effective Jan. 1. ... director for the agribusiness unit of Thermo Fisher Scientific, ... at Life Technologies. His extensive industry experience also includes ...
Breaking Biology Technology:
Cached News: